After ENHANCE, Now SEAS: What Do We Know, and How Do We Know It?

From: medvidblog
Type: Patients & People
Joined: April 2009
Videos: 180

Share this video

Added: April 29, 2009 | Time 02:55 | Views: 52

With more data about Vytorin and ezetimibe being presented at the European cardiology meeting, in this video blog Dr. Black discusses what we should think about the results, given their context.

Topics:

Tags: abnormalities, abnormality, aorta narrowing valve, aortic stenosis, disease, disorder, dyslipidemia, dyslipidemic, elevated, fat, hyperlipemia, hyperlipidemia, hyperlipidemias, hyperlipidemic, lipoatrophy, lipodystrophy, maldistribution

Embed:

Comments

Post a Comment

Please log in at the top of the page to post a comment!

Good News for Those Considering Becoming Living Kidney Donors
Posted By: medvidblog
Views: 196 Add to Favorites

Early Steroid Discontinuation After Kidney Transplantation: Long-term Outcomes
Posted By: medvidblog
Views: 181 Add to Favorites

IUDs: Trumping Myths With Evidence
Posted By: medvidblog
Views: 244 Add to Favorites

Recent Articles on Pneumonia and Tracheobronchitis
Posted By: medvidblog
Views: 218 Add to Favorites

Recent Breakthroughs in Pharmacogenomics
Posted By: medvidblog
Views: 213 Add to Favorites

Two Categories of Cancer Drugs?
Posted By: medvidblog
Views: 195 Add to Favorites

Survey Suggests That Cancer Patients May Be Willing to Participate in Clinical Trials
Posted By: medvidblog
Views: 284 Add to Favorites

Navigation

Community

Site Links

Resources / Support

By using this service, you accept our Terms of Service. Please read them. The health information on this site is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen.